Company

PERNIX THERAPEUTICS HOLDINGS, INC. (0001024126)

Standardized SEC financial data for PERNIX THERAPEUTICS HOLDINGS, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001024126 · Pharmaceutical Preparations.

Gross margin

69.5%

Operating margin

-69.3%

Net margin

-116.1%

Revenue growth (YoY)

-16.9%

Return on equity

97.3%

ROIC

-63.1%

Free cash flow

-$6.0M

Debt / equity

-1.92×

Ratios for fiscal year 2017, standardized from SEC filings.

Income statement

USD	FY2016	FY2017
Revenue	—	$146.1M
Cost of revenue	$43.3M	$44.6M
Gross profit	—	$101.4M
R&D expense	$6.1M	$787K
SG&A expense	$98.8M	$76.8M
Interest expense	$37.9M	$37.0M
Pretax income

Balance sheet

USD	FY2016	FY2017
Cash & equivalents	$36.4M	$32.8M
Inventory	$9.8M	$6.9M
Total current assets	$108.9M	$93.8M
Property, plant & equipment	$1.1M	$752K
Goodwill	$30.6M	$12.1M
Total assets	$310.4M	$205.5M
Total current liabilities

Cash flow

USD	FY2016	FY2017
Operating cash flow	-$16.5M	-$5.9M
Capital expenditures	$984K	$18K
Free cash flow	-$17.5M	-$6.0M
Investing cash flow	-$1.6M	$2.0M
Financing cash flow	-$1.7M	$402K
Dividends paid	$0	$0

Get 0001024126 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001024126/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001024126/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001024126 filings on SEC EDGAR →